As part of the Prediabetes Awareness & Action Initiative, the World Patients Alliance is engaging global health leaders, policymakers, and healthcare stakeholders through 02 formal advocacy letters.

These letters highlight the need for stronger attention to diabetes and prediabetes within global and national health priorities. They call for practical action on awareness, early risk identification, routine screening, prevention, timely care, and equitable access to essential diagnostic services.

Through this advocacy work, WPA aims to support stronger policy dialogue and encourage coordinated action on prediabetes as part of broader diabetes prevention, primary health care, universal health coverage, and noncommunicable disease strategies.

WPA’s advocacy letters under the Prediabetes Awareness & Action Initiative call for stronger global attention to prediabetes within diabetes prevention, NCD action, primary health care, and universal health coverage.

The first advocacy letter focuses on earlier risk identification, routine screening, prevention, timely care, affordable diagnostic services, and patient-centred approaches that support clear information, early action, and equitable access to care.

The second advocacy letter will be aligned with World Diabetes Day and its 2024–2026 theme, “Diabetes and Well-being.” It will further highlight the importance of prediabetes awareness, early action, and prevention as part of broader efforts to support physical, mental, and social well-being for people at risk of, or affected by, diabetes.

The letters featured below are the versions addressed to the Director-General of the World Health Organization.

Date: 21 May 2026
Issued by: World Patients Alliance

The letter calls for continued global attention to diabetes and prediabetes. It highlights the importance of earlier risk identification, routine screening, prevention, timely care, and equitable access to essential diagnostic services.

The letter also encourages greater policy attention to prediabetes as a preventable and manageable condition within broader diabetes, NCD, primary health care, and universal health coverage efforts.

WPA will continue to use formal advocacy, stakeholder engagement, and public awareness activities to advance the goals of the Prediabetes Awareness & Action Initiative.

By engaging global health institutions, policymakers, and healthcare leaders, WPA aims to support stronger recognition of prediabetes, encourage practical system-level action, and promote more equitable access to prevention, diagnosis, and care.

Prediabetes is an important stage where risk can be identified earlier and preventive action can begin. Stronger awareness, timely screening, and access to basic diagnostic services can help people at risk receive the support they need before diabetes and related complications develop.

Policy action is also necessary to strengthen prevention, improve early diagnosis, and reduce long-term pressure on individuals, families, health systems, and national economies.

Through these advocacy letters, WPA seeks to keep patient needs and prevention at the centre of diabetes-related policy discussions.